CRISPR-Based Gene Editing Approaches for Monogenic Diabetes Therapy and Precision Medicine
2025 | IDOSR JOURNAL OF APPLIED SCIENCES | Pp. 53-58
Monogenic diabetes represents approximately 1-5% of all diabetes cases globally, with mutations in over 40 genes causing various forms of maturity onset diabetes of the young (MODY) and neonatal diabetes mellitus. The emergence of clustered regularly interspa...